Nifty
Sensex
:
:
22212.70
73142.80
-4.75 (-0.02%)
-15.44 (-0.02%)

Pharmaceuticals & Drugs - Global

Rating :
46/99

BSE: 506690 | NSE: UNICHEMLAB

539.30
23-Feb-2024
  • Open
  • High
  • Low
  • Previous Close
  •  548.45
  •  551.45
  •  526.30
  •  543.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  33354
  •  180.07
  •  572.00
  •  271.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,802.61
  • 261.03
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,014.03
  • N/A
  • 1.53

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.22%
  • 0.40%
  • 15.62%
  • FII
  • DII
  • Others
  • 0.84%
  • 9.26%
  • 3.66%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.71
  • 2.48
  • 2.83

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -10.88
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 53.32
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.56
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.42
  • 0.78
  • 0.94

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.08
  • 29.51
  • 17.78

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
434.38
302.50
43.60%
415.63
328.82
26.40%
423.19
309.61
36.68%
402.10
369.95
8.69%
Expenses
396.26
345.26
14.77%
406.87
347.13
17.21%
395.17
310.57
27.24%
385.62
301.52
27.89%
EBITDA
38.12
-42.76
-
8.76
-18.31
-
28.02
-0.97
-
16.48
68.44
-75.92%
EBIDTM
8.77%
-14.14%
2.11%
-5.57%
6.62%
-0.31%
4.10%
18.50%
Other Income
11.28
16.35
-31.01%
5.54
9.21
-39.85%
8.63
7.85
9.94%
5.11
14.39
-64.49%
Interest
5.58
4.09
36.43%
6.73
4.69
43.50%
5.76
3.01
91.36%
5.52
1.59
247.17%
Depreciation
27.86
30.78
-9.49%
29.46
28.43
3.62%
28.77
24.54
17.24%
29.68
23.30
27.38%
PBT
83.97
-61.28
-
-21.88
-47.25
-
2.12
-20.68
-
-47.16
57.93
-
Tax
-0.02
2.65
-
2.61
23.41
-88.85%
2.79
2.69
3.72%
-2.89
-13.54
-
PAT
83.99
-63.93
-
-24.49
-70.67
-
-0.67
-23.37
-
-44.27
71.47
-
PATM
19.34%
-21.13%
-5.89%
-21.49%
-0.16%
-7.55%
-11.01%
19.32%
EPS
11.93
-9.08
-
-3.48
-10.04
-
-0.09
-3.32
-
-6.29
10.15
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
1,675.30
1,343.02
1,269.83
1,235.14
1,103.71
1,188.19
1,379.90
1,540.06
1,332.65
1,201.79
1,133.45
Net Sales Growth
27.80%
5.76%
2.81%
11.91%
-7.11%
-13.89%
-10.40%
15.56%
10.89%
6.03%
 
Cost Of Goods Sold
671.08
482.45
356.91
302.14
308.63
364.19
274.97
188.77
386.97
378.57
332.84
Gross Profit
1,004.22
860.57
912.92
933.00
795.08
823.99
1,104.93
1,351.28
945.67
823.23
800.61
GP Margin
59.94%
64.08%
71.89%
75.54%
72.04%
69.35%
80.07%
87.74%
70.96%
68.50%
70.63%
Total Expenditure
1,583.92
1,388.58
1,197.04
1,144.03
1,154.53
1,269.21
1,358.21
1,357.62
1,168.77
1,100.79
955.75
Power & Fuel Cost
-
102.84
78.05
68.89
73.02
76.39
49.23
41.62
38.25
39.39
35.97
% Of Sales
-
7.66%
6.15%
5.58%
6.62%
6.43%
3.57%
2.70%
2.87%
3.28%
3.17%
Employee Cost
-
356.41
330.49
306.97
273.28
238.52
200.64
169.04
255.92
223.20
187.37
% Of Sales
-
26.54%
26.03%
24.85%
24.76%
20.07%
14.54%
10.98%
19.20%
18.57%
16.53%
Manufacturing Exp.
-
194.60
193.21
215.73
232.08
147.23
125.30
103.70
150.54
145.03
137.05
% Of Sales
-
14.49%
15.22%
17.47%
21.03%
12.39%
9.08%
6.73%
11.30%
12.07%
12.09%
General & Admin Exp.
-
119.02
109.60
123.98
147.90
229.37
594.53
744.66
167.66
153.29
127.77
% Of Sales
-
8.86%
8.63%
10.04%
13.40%
19.30%
43.09%
48.35%
12.58%
12.76%
11.27%
Selling & Distn. Exp.
-
129.56
120.68
122.52
116.12
197.24
108.38
107.77
166.84
157.12
134.03
% Of Sales
-
9.65%
9.50%
9.92%
10.52%
16.60%
7.85%
7.00%
12.52%
13.07%
11.82%
Miscellaneous Exp.
-
3.70
8.11
3.81
3.50
16.26
5.16
2.06
2.58
4.19
134.03
% Of Sales
-
0.28%
0.64%
0.31%
0.32%
1.37%
0.37%
0.13%
0.19%
0.35%
0.06%
EBITDA
91.38
-45.56
72.79
91.11
-50.82
-81.02
21.69
182.44
163.88
101.00
177.70
EBITDA Margin
5.45%
-3.39%
5.73%
7.38%
-4.60%
-6.82%
1.57%
11.85%
12.30%
8.40%
15.68%
Other Income
30.56
38.52
47.51
50.19
91.31
98.41
3,278.19
5.50
19.11
20.72
42.38
Interest
23.59
17.31
6.11
5.12
7.85
7.52
8.01
3.36
2.90
3.04
3.19
Depreciation
115.77
113.44
91.17
84.36
81.67
67.37
50.51
43.52
38.79
41.27
45.72
PBT
17.05
-137.80
23.03
51.82
-49.02
-57.50
3,241.36
141.07
141.31
77.41
171.17
Tax
2.49
25.86
-11.09
17.15
11.97
-33.64
696.23
32.58
29.30
2.13
43.00
Tax Rate
14.60%
-14.66%
-48.15%
33.10%
-24.42%
58.50%
21.48%
23.09%
21.27%
2.75%
25.12%
PAT
14.56
-202.23
33.06
34.67
-61.00
-23.87
2,545.13
108.49
108.48
75.28
128.16
PAT before Minority Interest
14.56
-202.23
33.06
34.67
-61.00
-23.87
2,545.13
108.49
108.48
75.28
128.16
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
0.87%
-15.06%
2.60%
2.81%
-5.53%
-2.01%
184.44%
7.04%
8.14%
6.26%
11.31%
PAT Growth
116.83%
-
-4.64%
-
-
-
2,245.96%
0.01%
44.10%
-41.26%
 
EPS
2.07
-28.73
4.70
4.92
-8.66
-3.39
361.52
15.41
15.41
10.69
18.20

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
2,435.30
2,618.41
2,556.83
2,531.35
2,619.91
2,680.08
1,063.62
954.33
867.52
816.61
Share Capital
14.08
14.08
14.08
14.08
14.08
14.07
18.18
18.17
18.15
18.13
Total Reserves
2,409.18
2,593.65
2,535.00
2,512.44
2,601.99
2,665.42
1,044.00
935.01
848.52
797.74
Non-Current Liabilities
108.03
143.88
49.16
43.72
10.10
46.46
64.49
76.02
74.21
97.72
Secured Loans
63.65
89.01
0.00
0.00
0.00
0.33
0.44
22.98
20.35
24.65
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
41.91
39.96
30.41
23.51
14.60
10.76
25.33
12.58
8.88
7.64
Current Liabilities
639.60
552.13
505.76
566.73
502.92
463.51
392.62
275.09
211.76
230.32
Trade Payables
290.69
183.19
210.08
250.22
221.41
226.23
210.73
163.95
138.23
150.52
Other Current Liabilities
128.34
135.06
176.97
122.04
68.45
63.03
68.01
60.56
45.86
32.99
Short Term Borrowings
208.08
215.69
100.63
184.03
199.67
150.29
97.62
12.93
1.63
1.04
Short Term Provisions
12.50
18.19
18.09
10.44
13.39
23.97
16.25
37.65
26.05
45.78
Total Liabilities
3,182.93
3,314.42
3,111.75
3,141.80
3,132.93
3,190.05
1,520.73
1,305.44
1,153.49
1,144.65
Net Block
1,256.66
990.03
880.42
866.06
806.29
574.45
487.22
402.60
415.99
419.29
Gross Block
1,750.29
1,379.74
1,193.56
1,098.27
975.96
689.74
561.37
439.53
724.65
688.25
Accumulated Depreciation
493.63
389.70
313.14
232.21
169.67
115.29
74.15
36.92
308.66
268.96
Non Current Assets
1,591.06
1,666.02
1,734.44
1,455.33
1,093.64
853.59
772.27
673.34
589.07
563.97
Capital Work in Progress
147.45
493.81
567.50
330.47
92.39
238.15
249.98
237.13
122.64
90.54
Non Current Investment
0.16
0.28
159.12
134.38
129.20
9.20
9.51
5.54
5.83
5.72
Long Term Loans & Adv.
168.07
165.59
112.89
112.90
56.37
24.05
25.57
28.05
44.61
48.42
Other Non Current Assets
18.72
16.30
14.52
11.52
9.39
7.74
0.00
0.00
0.00
0.00
Current Assets
1,588.47
1,644.92
1,377.32
1,686.47
2,039.29
2,336.47
748.46
632.11
564.42
580.68
Current Investments
1.54
263.58
236.43
419.10
800.75
895.55
8.00
8.04
35.04
5.67
Inventories
625.23
600.22
538.34
396.54
338.66
272.86
281.71
230.57
207.68
203.49
Sundry Debtors
588.62
495.43
250.27
390.14
436.05
276.92
315.32
220.09
191.58
196.51
Cash & Bank
185.36
114.10
82.45
233.81
200.99
681.46
16.14
20.13
26.96
52.15
Other Current Assets
187.71
34.60
62.21
63.84
262.83
209.68
127.29
153.28
103.17
122.86
Short Term Loans & Adv.
156.40
136.99
207.62
183.04
194.18
145.51
98.80
122.77
82.25
105.67
Net Current Assets
948.86
1,092.80
871.56
1,119.74
1,536.37
1,872.95
355.84
357.02
352.66
350.36
Total Assets
3,179.53
3,310.94
3,111.76
3,141.80
3,132.93
3,190.06
1,520.73
1,305.45
1,153.49
1,144.65

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
-85.09
-259.61
32.98
19.82
-327.77
-112.34
68.19
111.91
78.10
86.73
PBT
-176.36
21.97
51.48
-48.21
-57.44
3,241.14
141.25
137.68
77.41
171.17
Adjustment
132.84
80.46
65.65
18.79
6.80
-3,207.66
53.31
39.65
35.57
18.74
Changes in Working Capital
-29.36
-354.43
-69.78
53.58
-264.94
-146.67
-98.65
-34.16
-16.49
-66.32
Cash after chg. in Working capital
-72.88
-252.00
47.35
24.15
-315.57
-113.20
95.91
143.16
96.49
123.58
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-12.21
-7.62
-14.36
-4.34
-12.20
0.86
-27.72
-31.25
-18.39
-36.85
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
202.81
102.40
-73.56
-35.91
-286.01
1,648.33
-127.87
-85.33
-52.34
35.70
Net Fixed Assets
-20.93
-121.73
-327.70
-338.73
-139.02
-107.71
-135.60
154.89
-73.58
38.14
Net Investments
349.28
134.15
147.92
374.24
-63.59
-889.36
17.40
42.09
-32.73
20.34
Others
-125.54
89.98
106.22
-71.42
-83.40
2,645.40
-9.67
-282.31
53.97
-22.78
Cash from Financing Activity
-81.30
191.23
-121.07
-62.30
-2.42
-881.13
59.23
-33.42
-50.95
-94.92
Net Cash Inflow / Outflow
36.42
34.01
-161.65
-78.40
-616.19
654.86
-0.46
-6.84
-25.19
27.51
Opening Cash & Equivalents
109.20
77.46
231.52
197.05
666.07
11.21
11.67
26.96
52.15
24.64
Closing Cash & Equivalent
183.75
109.20
77.46
231.52
197.05
666.07
11.21
20.13
26.96
52.15

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
344.18
370.38
362.05
358.85
371.69
380.95
116.88
104.93
95.48
90.02
ROA
-6.22%
1.03%
1.11%
-1.94%
-0.75%
108.06%
7.68%
8.82%
6.55%
11.56%
ROE
-8.04%
1.28%
1.37%
-2.37%
-0.90%
136.04%
10.77%
11.92%
8.95%
16.62%
ROCE
-5.60%
1.00%
2.12%
-1.49%
-1.77%
162.77%
13.42%
14.97%
9.29%
21.84%
Fixed Asset Turnover
0.86
0.99
1.08
1.06
1.43
2.21
3.08
2.32
1.71
1.67
Receivable days
147.31
107.17
94.63
136.61
109.51
78.30
63.41
55.72
58.55
64.53
Inventory Days
166.52
163.63
138.14
121.57
93.93
73.33
60.67
59.32
62.03
55.42
Payable days
179.25
201.09
278.03
76.39
73.41
94.97
104.25
52.00
52.61
62.52
Cash Conversion Cycle
134.58
69.71
-45.27
181.78
130.03
56.65
19.82
63.05
67.97
57.43
Total Debt/Equity
0.12
0.13
0.04
0.07
0.08
0.06
0.09
0.04
0.03
0.03
Interest Cover
-9.19
4.60
11.12
-5.25
-6.64
405.79
43.00
48.57
26.45
54.66

News Update:


  • Unichem Laboratories gets ANDA approval for Doxazosin tablets
    11th Jan 2024, 12:26 PM

    The product will be commercialized from Unichem’s Goa Plant

    Read More
  • Unichem Laboratories sells balance stake in Optimus Drugs
    5th Dec 2023, 11:18 AM

    In May 2022, the company sold 19.97% of equity shares of Optimus to Sekhmet Pharmaventures

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.